Literature DB >> 16467746

Contrast-induced nephropathy: epidemiology and prevention.

S M Bagshaw1, B F Culleton.   

Abstract

Contrast-induced nephropathy (CIN) is a leading cause of iatrogenic acute kidney failure. Periprocedural CIN results in a greater risk of requiring renal replacement therapy, prolonged hospitalization, excessive health care costs, potential long term kidney impairment and mortality. Identified risk factors for CIN include premorbid chronic kidney disease, diabetes mellitus, congestive heart failure, critical illness and volume of administered contrast media. Prophylactic interventions for the prevention of CIN remain controversial and uncertain. In this review we critically appraise the evidence for prevention of CIN. In general, every attempt should be made to correct underlying volume depletion, discontinue potential nephrotoxins, reverse any acute kidney dysfunction or when not possible, consider delay of procedure or an alternative modality for imaging. A minimum volume of contrast media should be employed, including going left ventriculogram and performing staged procedures if applicable. There are few interventions with quality evidence for reducing the incidence of CIN. procedure hydration and the use of nonionic iso-osmolar contrast media have consistently demonstrated efficacy. For patients at high risk, there is evidence to suggest benefit with N-acetylcysteine. Clinical studies with adenosine antagonists are encouraging; however, further confirmatory trials are required. Based on the available studies, there is inadequate evidence for the routine use of hemofiltration, atrial natriuretic peptides, calcium channel blockers, or prostaglandins. There is no evidence to support prophylaxis with diuretic therapy, forced diuresis, low dose dopamine, fenoldopam, captopril, or endothelin receptor antagonists. Despite recent advances in the epidemiology, pathophysiology and natural history of CIN, few effective prophylactic or therapeutic interventions have conclusively demonstrated evidence for a reduction in CIN incidence and no therapy has proven efficacious once CIN is established.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467746

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN: 0026-4725            Impact factor:   1.347


  10 in total

1.  Challenges to protocol optimization due to unexpected variation of CT contrast dose amount and flow.

Authors:  Tracy J Robinson; Jeffrey D Robinson; Daniel S Hippe; Lee M Mitsumori
Journal:  J Digit Imaging       Date:  2013-06       Impact factor: 4.056

2.  High Concentration of Iopromide Induces Apoptosis and Autophagy in Human Embryonic Kidney Cells via Activating a ROS-dependent Cellular Stress Pathway.

Authors:  Yuh-Feng Tsai; Jai-Sing Yang; Fuu-Jen Tsai; Yih-Dih Cheng; Yu-Jen Chiu; Shih-Chang Tsai
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

3.  Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.

Authors:  Sana Shoukat; Saqib A Gowani; Asif Jafferani; Sajid H Dhakam
Journal:  Cardiol Res Pract       Date:  2010-09-19       Impact factor: 1.866

4.  Comparison of N-acetylcysteine, ascorbic acid, and normal saline effect in prevention of contrast-induced nephropathy.

Authors:  Arsalan Khaledifar; Ali Momeni; Amrollah Ebrahimi; Soleiman Kheiri; Ali Mokhtari
Journal:  ARYA Atheroscler       Date:  2015-07

5.  Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy.

Authors:  Janneke Schilp; Carolien de Blok; Maaike Langelaan; Peter Spreeuwenberg; Cordula Wagner
Journal:  BMC Nephrol       Date:  2014-01-06       Impact factor: 2.388

6.  Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis of randomized controlled trials.

Authors:  Nana Duan; Jiegang Zhao; Zhuanzhen Li; Pingshuan Dong; Shaoxin Wang; Yuwei Zhao; Liping Wang; Hongyun Wang
Journal:  Med Sci Monit       Date:  2015-01-23

Review 7.  Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies.

Authors:  Erdmann Seeliger; Diana C Lenhard; Pontus B Persson
Journal:  Biomed Res Int       Date:  2014-02-23       Impact factor: 3.411

8.  Value of Image Fusion in Coronary Angiography for the Detection of Coronary Artery Bypass Grafts.

Authors:  Julien Plessis; Karine Warin Fresse; Zachary Cahouch; Thibaut Manigold; Vincent Letocart; Laurianne Le Gloan; Béatrice Guyomarch; Patrice Guerin
Journal:  J Am Heart Assoc       Date:  2016-06-10       Impact factor: 5.501

9.  The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM).

Authors:  Jai-Sing Yang; Yan-Ru Peng; Shih-Chang Tsai; Yeu-Sheng Tyan; Chi-Cheng Lu; Hong-Yi Chiu; Yu-Jen Chiu; Sheng-Chu Kuo; Yuh-Feng Tsai; Ping-Chin Lin; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2018-02-26

10.  Nitroxyl Radical as a Theranostic Contrast Agent in Magnetic Resonance Redox Imaging.

Authors:  Ken-Ichiro Matsumoto; Ikuo Nakanishi; Zhivko Zhelev; Rumiana Bakalova; Ichio Aoki
Journal:  Antioxid Redox Signal       Date:  2021-07-28       Impact factor: 8.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.